Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
Memphis, TN
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Methodist Healthcare - Memphis Hospitals
mi
from
Memphis, TN
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
Houston, TX
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Memorial Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
Worcester, MA
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
UMass Memorial
mi
from
Worcester, MA
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
Orange, CA
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
UCI Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
San Francisco, CA
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
California Pacific Medical Center (CPMC)
mi
from
San Francisco, CA
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
Baltimore, MD
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
Flint, MI
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
McLaren Flint Regional Medical Center
mi
from
Flint, MI
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
New York, NY
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Mount Sinai Health System
mi
from
New York, NY
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
Poughkeepsie, NY
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Vassar Brothers Medical Center
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
Harlingen, TX
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Valley Baptist Harlingen
mi
from
Harlingen, TX
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
Toronto, Ontario,
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Toronto Western Hospital
mi
from
Toronto, Ontario,
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
Phoenix, AZ
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
St. Joseph's Hospital and Medical Center - Dignity Health (BNI Phoenix)
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
Jacksonville, FL
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Baptist Medical Center Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
Iowa City, IA
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
Portland, ME
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Maine Medical Center
mi
from
Portland, ME
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
Philadelphia, PA
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
La Jolla, CA
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Scripps Memorial Hospital
mi
from
La Jolla, CA
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
West Palm Beach, FL
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Center for Advanced Research Excellence (St. Mary's Medical Center)
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated:  1/9/2018
mi
from
Houston, TX
Trevo® Retriever Registry Post Market Surveillance
Stryker Neurovascular Trevo® Retriever Registry
Status: Enrolling
Updated: 1/9/2018
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated:  1/9/2018
mi
from
Little Rock, AR
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated:  1/9/2018
mi
from
Aurora, CO
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated:  1/9/2018
mi
from
Atlanta, GA
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Emory University and Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated:  1/9/2018
mi
from
Peoria, IL
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
OSF Saint Francis Medical Center
mi
from
Peoria, IL
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated:  1/9/2018
mi
from
Indianapolis, IN
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
IU Health Neuroscience Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated:  1/9/2018
mi
from
Columbus, OH
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Riverside Methodist Hospital (OhioHealth)
mi
from
Columbus, OH
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated:  1/9/2018
mi
from
Milwaukee, WI
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
Aurora Health Care, Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated:  1/9/2018
mi
from
Saint Louis, MO
Evaluation of Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Minimally Invasive Subcortical Parafascicular Access for Clot Evacuation
Status: Enrolling
Updated: 1/9/2018
St. Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
Phase IIA Study of the Safety and Tolerability of the Use of Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
Status: Enrolling
Updated:  1/9/2018
mi
from
New York, NY
Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
Phase IIA Study of the Safety and Tolerability of the Use of Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
Status: Enrolling
Updated: 1/9/2018
Hospital for Special Surgery
mi
from
New York, NY
Click here to add this to my saved trials
Cognitive Rehabilitation:ACTION Training for Soldiers With Executive Dysfunction
Cognitive Rehabilitation:ACTION Training for Soldiers With Executive Dysfunction
Status: Enrolling
Updated:  1/9/2018
mi
from
Fort Campbell North, KY
Cognitive Rehabilitation:ACTION Training for Soldiers With Executive Dysfunction
Cognitive Rehabilitation:ACTION Training for Soldiers With Executive Dysfunction
Status: Enrolling
Updated: 1/9/2018
Fort Campbell Intrepid Spirit
mi
from
Fort Campbell North, KY
Click here to add this to my saved trials
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
Patient and Caregiver Quality of Life in the Treatment of Atopic Dermatitis in Pediatric Patients: a Comparison Between a General Pediatric Practice and a Pediatric Dermatology Practice
Status: Enrolling
Updated:  1/9/2018
mi
from
New Haven, CT
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
Patient and Caregiver Quality of Life in the Treatment of Atopic Dermatitis in Pediatric Patients: a Comparison Between a General Pediatric Practice and a Pediatric Dermatology Practice
Status: Enrolling
Updated: 1/9/2018
Yale Dermatology Associates
mi
from
New Haven, CT
Click here to add this to my saved trials
Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG
A Phase I-II Study of Acupuncture for the Treatment of Chronic, Taxane-Induced Peripheral Neuropathy in Breast Cancer Survivors
Status: Enrolling
Updated:  1/10/2018
mi
from
Houston, TX
Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG
A Phase I-II Study of Acupuncture for the Treatment of Chronic, Taxane-Induced Peripheral Neuropathy in Breast Cancer Survivors
Status: Enrolling
Updated: 1/10/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle
Optical Imaging of Dystrophic and Damaged Muscle
Status: Enrolling
Updated:  1/10/2018
mi
from
Gainesville, FL
Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle
Optical Imaging of Dystrophic and Damaged Muscle
Status: Enrolling
Updated: 1/10/2018
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in Spastic Esophageal Disorders
Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in the Treatment of Medical Refractory Spastic Esophageal Disorders
Status: Enrolling
Updated:  1/10/2018
mi
from
Baltimore, MD
Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in Spastic Esophageal Disorders
Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in the Treatment of Medical Refractory Spastic Esophageal Disorders
Status: Enrolling
Updated: 1/10/2018
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Computerized Cognitive Intervention in the Oldest-Old
Computerized Cognitive Intervention in the Oldest-Old: A Feasibility Study
Status: Enrolling
Updated:  1/10/2018
mi
from
New York, NY
Computerized Cognitive Intervention in the Oldest-Old
Computerized Cognitive Intervention in the Oldest-Old: A Feasibility Study
Status: Enrolling
Updated: 1/10/2018
Jewish Home Lifecare
mi
from
New York, NY
Click here to add this to my saved trials
Computerized Cognitive Intervention in the Oldest-Old
Computerized Cognitive Intervention in the Oldest-Old: A Feasibility Study
Status: Enrolling
Updated:  1/10/2018
mi
from
New York, NY
Computerized Cognitive Intervention in the Oldest-Old
Computerized Cognitive Intervention in the Oldest-Old: A Feasibility Study
Status: Enrolling
Updated: 1/10/2018
Icahn School of Medicine at Mount Sinia
mi
from
New York, NY
Click here to add this to my saved trials
Effects of Vaporized Marijuana on Neuropathic Pain
CCRC: The Analgesic Effect of Vaporized Cannabis on Neuropathic Pain
Status: Enrolling
Updated:  1/11/2018
mi
from
Sacramento, CA
Effects of Vaporized Marijuana on Neuropathic Pain
CCRC: The Analgesic Effect of Vaporized Cannabis on Neuropathic Pain
Status: Enrolling
Updated: 1/11/2018
CTSC Clinical Research Center, Sacramento VA Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Dose Finding and Safety Study of Deferoxamine in Patients With Brain Hemorrhage
Safety and Tolerability of Deferoxamine in Acute Cerebral Hemorrhage
Status: Enrolling
Updated:  1/11/2018
mi
from
Boston, MA
Dose Finding and Safety Study of Deferoxamine in Patients With Brain Hemorrhage
Safety and Tolerability of Deferoxamine in Acute Cerebral Hemorrhage
Status: Enrolling
Updated: 1/11/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug
An Open-label Eslicarbazepine Acetate Long-term Safety and Tolerability Study in Children and Adolescents (4 - 17 Years)
Status: Enrolling
Updated:  1/11/2018
mi
from
Henderson, NV
A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug
An Open-label Eslicarbazepine Acetate Long-term Safety and Tolerability Study in Children and Adolescents (4 - 17 Years)
Status: Enrolling
Updated: 1/11/2018
Child Neurology Specialists / Clinical Research Center of Nevada, LLC
mi
from
Henderson, NV
Click here to add this to my saved trials
Delirium in Persons With Dementia
Delirium in Persons With Dementia
Status: Enrolling
Updated:  1/11/2018
mi
from
State College, PA
Delirium in Persons With Dementia
Delirium in Persons With Dementia
Status: Enrolling
Updated: 1/11/2018
Mount Nittany Medical Center
mi
from
State College, PA
Click here to add this to my saved trials
Use of Neuromuscular Electrostimulation (NMES) for Treatment or Prevention of ICU-Associated Weakness
Use of Neuromuscular Electrostimulation (NMES) for Treatment or Prevention of ICU-Associated Weakness
Status: Enrolling
Updated:  1/12/2018
mi
from
Baltimore, MD
Use of Neuromuscular Electrostimulation (NMES) for Treatment or Prevention of ICU-Associated Weakness
Use of Neuromuscular Electrostimulation (NMES) for Treatment or Prevention of ICU-Associated Weakness
Status: Enrolling
Updated: 1/12/2018
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/12/2018
mi
from
Hamden, CT
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Hamden Public Schools
mi
from
Hamden, CT
Click here to add this to my saved trials
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/12/2018
mi
from
New Haven, CT
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Department of Psychiatry, Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/12/2018
mi
from
New Haven, CT
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Yale Child Study Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/12/2018
mi
from
Beijing,
Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)
Integrated Brain, Body and Social Intervention (IBBS) for Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/12/2018
Capital Medical University
mi
from
Beijing,
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
mi
from
Fresno, CA
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
University of California San Francisco-Fresno
mi
from
Fresno, CA
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
mi
from
Los Angeles, CA
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
mi
from
Orange, CA
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
The University of California Irvine
mi
from
Orange, CA
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
mi
from
Sacramento, CA
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
University of California at Davis Health System
mi
from
Sacramento, CA
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
mi
from
New Haven, CT
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated:  1/12/2018
mi
from
Jacksonville, FL
Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG)
Status: Enrolling
Updated: 1/12/2018
University of Florida Health Science Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials